Unknown

Dataset Information

0

Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).


ABSTRACT: OBJECTIVE:The programed death-1 (PD1)/programed death-ligand 1 (PD-L1) pathway plays a critical role in balancing immunity and host immunopathology. During chronic HIV/SIV infection, there is persistent immune activation accompanied by accumulation of virus-specific cells with terminally differentiated phenotypes and expression of regulatory receptors such as PD1. These observations led us to hypothesize that the PD1/PD-L1 pathway contributes to the functional dysregulation and ineffective viral control, and its blockade may be a potential immunotherapeutic target. METHODS:Lymph node biopsies from HIV-infected patients (n?=?23) were studied for expression of PD1 and PD-L1. In addition, we assessed the safety and biological activity of a human anti-PD-L1 antibody (Avelumab) in chronically SIV-infected rhesus macaques. RESULTS:PD-L1 expression was observed in cells with myloid/macrophage morphology in HIV-infected lymph nodes. Administration of anti-PD-L1 was well tolerated, and no changes in body weights, hematologic, or chemistry parameters were observed during the study. Blockade of PD-L1 led to a trend of transient viral control after discontinuation of treatment. CONCLUSION:Administration of anti-PD-L1 in chronic SIV-infected rhesus macaques was well tolerated. Overall, these data warrant further investigation to assess the efficacy of anti-PD-L1 treatment on viral control in chronic SIV infection as a prelude to such therapy in humans.

SUBMITTER: Gill AL 

PROVIDER: S-EPMC5051527 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).

Gill Amanda L AL   Green Samantha A SA   Abdullah Shahed S   Le Saout Cecile C   Pittaluga Stefania S   Chen Hui H   Turnier Refika R   Lifson Jeffrey J   Godin Steven S   Qin Jing J   Sneller Michael C MC   Cuillerot Jean-Marie JM   Sabzevari Helen H   Lane H Clifford HC   Catalfamo Marta M  

AIDS (London, England) 20161001 16


<h4>Objective</h4>The programed death-1 (PD1)/programed death-ligand 1 (PD-L1) pathway plays a critical role in balancing immunity and host immunopathology. During chronic HIV/SIV infection, there is persistent immune activation accompanied by accumulation of virus-specific cells with terminally differentiated phenotypes and expression of regulatory receptors such as PD1. These observations led us to hypothesize that the PD1/PD-L1 pathway contributes to the functional dysregulation and ineffecti  ...[more]

Similar Datasets

| S-EPMC5757373 | biostudies-literature
| S-EPMC10544331 | biostudies-literature
| S-EPMC3624378 | biostudies-literature
| S-EPMC5030343 | biostudies-literature
2022-08-08 | GSE165519 | GEO
| S-EPMC5095489 | biostudies-literature
| S-EPMC7337596 | biostudies-literature
2017-04-26 | GSE98211 | GEO
| S-EPMC6041778 | biostudies-literature
| S-EPMC3499432 | biostudies-literature